ArticleFrontiers in cell and developmental biology2026
Effectiveness comparison of pembrolizumab versus other immune checkpoint inhibitors in neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma.
Mingduan Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.